These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 31993888)

  • 21. Treating psoriatic arthritis to target: discordance between physicians and patients' assessment, non-adherence, and restricted access to drugs precluded therapy escalation in a real-world cohort.
    Ferreira MF; Kohem CL; Xavier RM; Abegg E; Martins OS; Resmini MB; de Mello AL; de Almeida Menegat F; Hax V; Gasparin AA; Brenol CV; de Andrade NPB; Viecceli D; Brenol JCT; Palominos PE
    Clin Rheumatol; 2019 Mar; 38(3):961-968. PubMed ID: 30511296
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Patient perspectives in the management of psoriasis: results from the population-based Multinational Assessment of Psoriasis and Psoriatic Arthritis Survey.
    Lebwohl MG; Bachelez H; Barker J; Girolomoni G; Kavanaugh A; Langley RG; Paul CF; Puig L; Reich K; van de Kerkhof PC
    J Am Acad Dermatol; 2014 May; 70(5):871-81.e1-30. PubMed ID: 24576585
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Exploring the Quality of Communication Between Patients with Psoriatic Arthritis and Physicians: Results of a Global Online Survey.
    Coates LC; Azevedo VF; Cappelleri JC; Moser J; Eder L; Richette P; Weng MY; Silva RQ; Garg A; Majjhoo A; Griffiths CEM; Young P; Howland S
    Rheumatol Ther; 2021 Dec; 8(4):1741-1758. PubMed ID: 34570345
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treat-to-target in PsA: methods and necessity.
    Dures E; Shepperd S; Mukherjee S; Robson J; Vlaev I; Walsh N; Coates LC
    RMD Open; 2020 Feb; 6(1):. PubMed ID: 32071281
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Remission criteria and activity indices in psoriatic arthritis.
    Acosta Felquer ML; Ferreyra Garrott L; Marin J; Catay E; Scolnik M; Scaglioni V; Ruta S; Rosa J; Soriano ER
    Clin Rheumatol; 2014 Sep; 33(9):1323-30. PubMed ID: 24820142
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Assessment of the Patient Acceptable Symptom State (PASS) in psoriatic arthritis: association with disease activity and quality of life indices.
    Lubrano E; Scriffignano S; Azuaga AB; Ramirez J; Cañete JD; Perrotta FM
    RMD Open; 2020 Mar; 6(1):. PubMed ID: 32179713
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Results of a global, patient-based survey assessing the impact of psoriatic arthritis discussed in the context of the Psoriatic Arthritis Impact of Disease (PsAID) questionnaire.
    Coates LC; Orbai AM; Azevedo VF; Cappelleri JC; Steinberg K; Lippe R; Lim I; Eder L; Richette P; Weng MY; Queiro Silva R; Fallon L
    Health Qual Life Outcomes; 2020 Jun; 18(1):173. PubMed ID: 32513190
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Real world effectiveness and satisfaction with secukinumab in the treatment of patients with psoriatic arthritis: a population survey in five European countries.
    Conaghan PG; Keininger DL; Holdsworth EA; Booth N; Modi NN; Tian H; Kiltz U
    Curr Med Res Opin; 2021 Oct; 37(10):1845-1853. PubMed ID: 34256669
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Analysis of treatment goal alignment between Japanese psoriasis patients and their paired treating physicians.
    Okubo Y; Tsuruta D; Tang AC; Inoue S; Torisu-Itakura H; Hanada T; Ohtsuki M
    J Eur Acad Dermatol Venereol; 2018 Apr; 32(4):606-614. PubMed ID: 29034518
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association Between Comorbidities and Quality of Life in Psoriatic Arthritis: Results from a Multicentric Cross-sectional Study.
    Bavière W; Deprez X; Houvenagel E; Philippe P; Deken V; Flipo RM; Paccou J
    J Rheumatol; 2020 Mar; 47(3):369-376. PubMed ID: 31203223
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment Switch Patterns and Healthcare Costs in Biologic-Naive Patients with Psoriatic Arthritis.
    Wu JJ; Pelletier C; Ung B; Tian M; Khilfeh I; Curtis JR
    Adv Ther; 2020 May; 37(5):2098-2115. PubMed ID: 32141018
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Early treatment of psoriatic arthritis is associated with improved patient-reported outcomes: findings from the etanercept PRESTA trial.
    Kirkham B; de Vlam K; Li W; Boggs R; Mallbris L; Nab HW; Tarallo M
    Clin Exp Rheumatol; 2015; 33(1):11-9. PubMed ID: 25535650
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Residual disease activity and treatment adjustments in psoriatic arthritis in current clinical practice.
    van Mens LJJ; van de Sande MGH; Fluri IA; Atiqi S; van Kuijk AWR; Baeten DLP
    Arthritis Res Ther; 2017 Oct; 19(1):226. PubMed ID: 29017591
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effectiveness and safety of ustekinumab in naïve or TNF-inhibitors failure psoriatic arthritis patients: a 24-month prospective multicentric study.
    Chimenti MS; Ortolan A; Lorenzin M; Triggianese P; Talamonti M; Costa L; Caso F; Favero M; Teoli M; Galluzzo M; Scarpa R; Punzi L; Perricone R; Ramonda R
    Clin Rheumatol; 2018 Feb; 37(2):397-405. PubMed ID: 29302829
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A patient and physician survey of fibromyalgia across Latin America and Europe.
    Clark P; Paiva ES; Ginovker A; Salomón PA
    BMC Musculoskelet Disord; 2013 Jun; 14():188. PubMed ID: 23767857
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of Composite Indices Tailored for Psoriatic Arthritis Treated with csDMARD and bDMARD: A Cross-sectional Analysis of a Longitudinal Cohort.
    Lubrano E; De Socio A; Perrotta FM
    J Rheumatol; 2017 Aug; 44(8):1159-1164. PubMed ID: 28572467
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Psoriatic arthritis in Canadian clinical practice: the PsA assessment in rheumatology.
    Gladman DD; Chandran V; Thavaneswaran A; Zummer M
    J Rheumatol; 2012 Sep; 39(9):1850-3. PubMed ID: 22859361
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Degree of Alignment Between Japanese Patients and Physicians on Alopecia Areata Disease Severity and Treatment Satisfaction: A Real-World Survey.
    Nakamura K; Kamei K; Austin J; Marwaha S; Piercy J; Anderson P; Sakaki-Yumoto M; Ohyama M
    Dermatol Ther (Heidelb); 2024 Jan; 14(1):151-167. PubMed ID: 38079099
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The psychosocial burden of psoriatic arthritis.
    Husni ME; Merola JF; Davin S
    Semin Arthritis Rheum; 2017 Dec; 47(3):351-360. PubMed ID: 28802776
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pain Mechanisms and Ultrasonic Inflammatory Activity as Prognostic Factors in Patients With Psoriatic Arthritis: A Prospective Cohort Study.
    Højgaard P; Ellegaard K; Nielsen SM; Christensen R; Guldberg-Møller J; Ballegaard C; Dreyer L; Mease P; de Wit M; Skov L; Glintborg B; Bliddal H; Bartels EM; Amris K; Kristensen LE
    Arthritis Care Res (Hoboken); 2019 Jun; 71(6):798-810. PubMed ID: 29975012
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.